Sudden cardiac death · participants with high risk of sudden cardiac death (primary prevention)
Amiodarone may leads to lower sudden cardiac death compared with placebo or no treatment (low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
Amiodarone showed no clear difference in all‐cause mortality compared with other antiarrhythmics (low certainty).
1 finding from 1 review
Sudden cardiac death · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes sudden cardiac death compared with beta blockers (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes all‐cause mortality compared with beta blockers (very low certainty).
1 finding from 1 review
Sudden cardiac death · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes sudden cardiac death compared with sotalol (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes all‐cause mortality compared with sotalol (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (primary prevention)
Amiodarone showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).
1 finding from 1 review
Sudden cardiac death · beta blockers
Amiodarone showed no clear difference in sudden cardiac death compared with beta blockers (low certainty).
1 finding from 1 review
All‐cause mortality · beta blockers
Amiodarone may leads to lower all‐cause mortality compared with beta blockers (low certainty).
1 finding from 1 review
Sudden cardiac death · participants with high risk of sudden cardiac death (primary prevention)
Amiodarone showed no clear difference in sudden cardiac death compared with other antiarrhythmics (moderate certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (primary prevention)
Amiodarone probably leads to lower all‐cause mortality compared with other antiarrhythmics (moderate certainty).
1 finding from 1 review
Sudden cardiac death · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes sudden cardiac death compared with placebo or no treatment (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Sudden cardiac death · participants with high risk of sudden cardiac death (secondary prevention)
It is very uncertain whether amiodarone changes sudden cardiac death compared with other antiarrhythmics (very low certainty).
1 finding from 1 review
Intervention not reported
Occurrence of angiographic restenosis [ · participants with CHD after PCI
The intervention may leads to lower occurrence of angiographic restenosis [ (low certainty).
1 finding from 1 review
Intervention not reported
Adverse event · participants with CHD after PCI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Occurence of myocardial infarction [ · participants with CHD after PCI
The intervention may leads to lower occurence of myocardial infarction [ (low certainty).
1 finding from 1 review
Intervention not reported
Occurrence of angina [ · participants with CHD after PCI
It is very uncertain whether the intervention changes occurrence of angina [ (very low certainty).
1 finding from 1 review
Intervention not reported
Occurence of heart failure [ · participants with CHD after PCI
The intervention may leads to lower occurence of heart failure [ (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality [ · participants with CHD after PCI
It is very uncertain whether the intervention changes all‐cause mortality [ (very low certainty).
1 finding from 1 review